Literature DB >> 6359997

Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

A M Macher, J A Kovacs, V Gill, G D Roberts, J Ames, C H Park, S Straus, H C Lane, J E Parrillo, A S Fauci.   

Abstract

The presence of Mycobacterium avium-intracellulare has frequently been demonstrated in tissue specimens from patients with the acquired immunodeficiency syndrome. The importance of this mycobacterium as a cause of constitutional symptoms and organ dysfunction has been unclear, however, because of the sparse inflammatory response evoked and the frequent concurrence of other pathogenic organisms. We detected M. avium-intracellulare in blood samples from eight patients with the acquired immunodeficiency syndrome, seven of whom had a previously recognized M. avium-intracellulare infection. Blood cultures were positive on 1 to 14 occasions over 135 days using the Dupont isolator system or the Bactec 12B medium system. Cultures were positive within 14 to 51 or 7 to 14 days with the respective techniques. The ability to rapidly isolate M. avium-intracellulare from blood may provide a useful diagnostic technique for detecting disseminated mycobacterial disease in patients with the acquired immunodeficiency syndrome as well as in other patient populations. This technique may also be useful for assessing the efficacy of drug therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6359997     DOI: 10.7326/0003-4819-99-6-782

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  38 in total

Review 1.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Comparative recoveries of Mycobacterium avium-M. intracellulare from isolator lysis-centrifugation and BACTEC 13A blood culture systems.

Authors:  T E Kiehn; R Cammarata
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

3.  Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; R Cammarata
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

Review 4.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

5.  Choroidal lesions in patients with AIDS.

Authors:  M A Rosenblatt; C Cunningham; S Teich; A H Friedman
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

Review 6.  Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.

Authors:  A Pozniak; M R Nelson
Journal:  Genitourin Med       Date:  1996-08

7.  Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals.

Authors:  B Y Lee; D Chatterjee; C M Bozic; P J Brennan; D L Cohn; J D Bales; S M Harrison; L A Andron; I M Orme
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

8.  Isolation and characterization of a recombinant lambda gt11 bacteriophage which expresses an immunoreactive Mycobacterium intracellulare protein in Escherichia coli.

Authors:  S L Morris; D A Rouse; D Hussong; S D Chaparas
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

10.  Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses.

Authors:  I M Orme; S K Furney; A D Roberts
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.